Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 1695-1696, 2000;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swaminathan, R.
Right arrow Articles by Spector, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swaminathan, R.
Right arrow Articles by Spector, T.
Related Collections
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2000;46:1695-1696.)
© 2000 American Association for Clinical Chemistry, Inc.


Technical Briefs

Serum Creatinine and Fat-free Mass (Lean Body Mass)

R. Swaminathan1,a, Phillipa Major2, Harold Snieder2 and Timothy Spector2

1 Department of Chemical Pathology and
2 Twin Research Unit, The Guy’s, King’s College and St. Thomas’ Medical and Dental School, St. Thomas’ Campus, London, United Kingdom SE1 7EH
a author for correspondence: fax 44-20-7-928-4226, e-mail r.swaminathan{at}kcl.ac.uk

Serum creatinine is widely used as an index of glomerular filtration rate (GFR) (1). However, it is not a sensitive index because GFR may have to decrease by >50% before serum creatinine becomes "abnormal", and this may be at least partly attributable to the wide reference interval for serum creatinine (44–124 µmol/L). One of the factors influencing the creatinine concentration is said to be muscle mass (1)(2). Thus, it can be argued that if the reference interval for serum creatinine can be adjusted for muscle mass, serum creatinine may be a better index of GFR. However, there is little information on the relationship between muscle mass and serum creatinine. We previously have shown that the contribution of lean body mass (LBM) to the variation in serum creatinine in healthy subjects is small (3). In this report, we extend these observations to another group and used a more precise method to measure LBM.

We studied 664 female subjects (age range, 19–76 years) who attended the Twin Research Unit as part of a larger study. Of these, 346 were monozygotic and 318 were dizygotic twins. Body composition (total fat mass and LBM) was determined by dual energy x-ray absorptiometry using a QDR 2000 scanner (Hologic). The long-term imprecision with this scanner is 2%. Fasting blood samples were obtained from all subjects, and serum creatinine was measured by an enzymatic method on a dry chemistry analyzer (Vitros 950; Johnson & Johnson Diagnostic). The CV of the method is 3% at a concentration of 120 µmol/L.

The age, height, weight, total fat mass, LBM, and serum urea and creatinine values for the group are shown in Table 1 . Simple correlation analysis with correction for the dependency between observation of twin pairs (using the Generalised Estimating Equation) showed that serum creatinine was correlated significantly with LBM (r = 0.171; P <0.0001), percentage of body fat (r = -0.10; P = 0.011), and age (r = 0.152; P <0.0001) but not with body mass index or total fat mass. When stepwise multiple regression analysis was done using serum creatinine as the dependent variable, and age, percentage of fat, and LBM as independent variables, the contributions of LBM, age, and percentage of fat to the variation of the serum creatinine were 2.9%, 2.1%, and 0.9%, respectively. To exclude the contribution of genetic influences, the analysis was done with one of the twins, and the contributions for LBM, age, and fat were 3.8%, 1.9%, and 2.1%, respectively.


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of the subjects.

Creatinine is produced nonenzymatically in the skeletal muscle, and the amount of creatinine production, and therefore the 24 h excretion of creatinine, is directly related to muscle mass (4). This relationship has been used to predict muscle mass from creatinine excretion (5)(6). In estimating GFR from serum creatinine, body weight is included in the formula (7) or nomogram (8) to allow for variation in creatinine excretion.

When interpreting serum creatinine, it is believed that LBM should be taken into account (1). However, as shown here and previously (3), the contribution of LBM to variations in serum creatinine is small. The group of subjects studied were all females, and this may account for the low contribution. However, their LBM covered a wide range (23.0–53.7 kg), and thus it is likely that the findings here would be widely applicable.

These results suggest that although creatinine production increases with increasing LBM, there is a concomitant increase in the volume of distribution of creatinine, thereby reducing the relationship between serum creatinine and LBM. Total body water is related to LBM, and Shutte et al. (9) have shown that LBM and total plasma creatinine (plasma volume x creatinine concentration) are well correlated.

We conclude that the contribution of LBM to serum creatinine is small and that correction of serum creatinine according to LBM is unlikely to improve the usefulness of this measurement.


References

  1. Marshall WJ. The kidneys, renal function and renal failure. Marshall WJ Bangert SK eds. Clinical biochemistry, metabolic and clinical aspects 1997:117-142 Churchill Livingstone London. .
  2. Shea PH, Maher JF, Horak E. Prediction of glomerular filtration rate by serum creatinine and ß-2-microglobulin. Nephron 1981;29:30-35.[ISI][Medline] [Order article via Infotrieve]
  3. Swaminathan R, Ho CS, Chu LM, Donnan S. Relation between plasma creatinine and body size. Clin Chem 1986;32:371-373.[Abstract/Free Full Text]
  4. Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr 1976;29:1359-1366.[Abstract/Free Full Text]
  5. Heymsfield SB, Artega C, McMans C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr 1983;37:478-494.[Abstract/Free Full Text]
  6. Proctor DN, O’Brien PC, Atkinson EJ, Nair KS. Comparison of techniques to estimate total body skeletal mass in people of different age groups. Am J Physiol 1999;277:E489-E495.[Abstract/Free Full Text]
  7. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.[ISI][Medline] [Order article via Infotrieve]
  8. Bjornsson TD, Cocchetto DM, McGowan FX, Veghese CP, Sedor F. Nomogram for estimating creatinine clearance. Clin Pharmacokinet 1983;8:365-369.[ISI][Medline] [Order article via Infotrieve]
  9. Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. Total plasma creatinine: an accurate measurement of total striated muscle mass. J Appl Physiol 1981;51:762-766.[Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
Nephrol Dial TransplantHome page
J. H. Macdonald, S. M. Marcora, M. Jibani, G. Roberts, M. J. Kumwenda, R. Glover, J. Barron, and A. B. Lemmey
Bioelectrical impedance can be used to predict muscle mass and hence improve estimation of glomerular filtration rate in non-diabetic patients with chronic kidney disease
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3481 - 3487.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
G Banfi, M Del Fabbro, and G Lippi
Relation between serum creatinine and body mass index in elite athletes of different sport disciplines * Commentary
Br. J. Sports Med., August 1, 2006; 40(8): 675 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. H. Jafar, C. H. Schmid, and A. S. Levey
Serum Creatinine as Marker of Kidney Function in South Asians: A Study of Reduced GFR in Adults in Pakistan
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1413 - 1419.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swaminathan, R.
Right arrow Articles by Spector, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swaminathan, R.
Right arrow Articles by Spector, T.
Related Collections
Right arrow General Clinical Chemistry


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS